Age, Biography and Wiki
Adrian Krainer (scientist) (Adrian Roberrt Krainer) was born on 1958 in Montevideo, Uruguay, is a Uruguayan neuroscientist. Discover Adrian Krainer (scientist)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 66 years old?
| Popular As |
Adrian Roberrt Krainer |
| Occupation |
N/A |
| Age |
66 years old |
| Zodiac Sign |
|
| Born |
1958 |
| Birthday |
1958 |
| Birthplace |
Montevideo, Uruguay |
| Nationality |
Uruguay
|
We recommend you to check the complete list of Famous People born on 1958.
He is a member of famous with the age 66 years old group.
Adrian Krainer (scientist) Height, Weight & Measurements
At 66 years old, Adrian Krainer (scientist) height not available right now. We will update Adrian Krainer (scientist)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Who Is Adrian Krainer (scientist)'s Wife?
His wife is Kate Krainer
| Family |
| Parents |
Not Available |
| Wife |
Kate Krainer |
| Sibling |
Not Available |
| Children |
3 |
Adrian Krainer (scientist) Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Adrian Krainer (scientist) worth at the age of 66 years old? Adrian Krainer (scientist)’s income source is mostly from being a successful . He is from Uruguay. We have estimated Adrian Krainer (scientist)'s net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Adrian Krainer (scientist) Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Adrian Robert Krainer is a Uruguayan-American biochemist and molecular geneticist known for his research into RNA gene-splicing.
He helped create a drug for patients with spinal muscular atrophy.
Krainer holds the St. Giles Foundation Professorship at Cold Spring Harbor Laboratory in Laurel Hollow, New York.
Krainer was born in Montevideo, Uruguay to a Jewish family of Hungarian and Romanian descent.
He has one older brother, who is a chemical engineer.
His father did forced labor for two years in a Romanian labor camp (Ferma Alba) during World War II.
After the war, his father's original surname, Kreiner changed to Krainer due to a clerical error when he was a refugee in Italy.
His parents owned a small leather business in Montevideo.
Krainer attended a private bilingual French-Spanish elementary school.
He later attended a public school for two years before completing his pre-college education with four years at a private Spanish-Hebrew school.
Krainer lived through political unrest during his teenage years, including urban guerrilla and military dictatorship.
Krainer received a full scholarship from Columbia University and completed a Bachelor of Arts degree in Biochemistry in 1981.
He graduated cum laude and Phi Beta Kappa.
In 1986, he earned a Doctor of Philosophy degree in biochemistry from Harvard University.
From 1986 to 1989, Krainer conducted postdoctoral research as the first Cold Spring Harbor Fellow at the Cold Spring Harbor Laboratory.
Krainer worked as an assistant professor from 1989 to 1990, Associate Professor from 1990 to 1994, and Professor since 1994.
Krainer is a faculty member of the graduate programs in Genetics, Molecular and Cellular Biology, and Molecular Genetics and Microbiology at State University of New York, Stony Brook.
Krainer holds the St. Giles Foundation Professorship at Cold Spring Harbor Laboratory.
Krainer is a co-founder and Director of Stoke Therapeutics, based in Bedford, MA.
In 2021 Krainer received the Wolf Prize in Medicine.
In 2019 he was awarded a Breakthrough Prize in Life Sciences for his contributions to the understanding of the RNA gene-splicing process and, in collaboration with fellow Prize Laureate Dr. Frank Bennet of Ionis Pharmaceuticals, the development of medical interventions that target the RNA-splicing process, including Spinraza, which is the first treatment for the genetic disorder Spinal Muscular Atrophy. Other honors include:
Krainer's father and maternal grandparents were Holocaust refugees.
He has three children, Emily, Andrew, and Brian.
His wife, Kate Krainer, is a plant geneticist.
